Ritter Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch RTTR and buy or sell other stocks, options, and ETFs commission-free!About RTTR
Ritter Pharmaceuticals, Inc. engages in the development of novel therapeutic products which modulate the human gut microbiome to treat digestive disorders and gastrointestinal diseases. It focuses on the development and commercialization of RP-G28.
CEOAndrew J. Ritter, MBA
CEOAndrew J. Ritter, MBA
Employees38
Employees38
HeadquartersLos Angeles, California
HeadquartersLos Angeles, California
Founded2004
Founded2004
Employees38
Employees38
RTTR Key Statistics
Market cap56.59M
Market cap56.59M
Price-Earnings ratio-0.11
Price-Earnings ratio-0.11
Dividend yield—
Dividend yield—
Average volume104.16K
Average volume104.16K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.26
52 Week high$1.26
52 Week low$0.337
52 Week low$0.337